Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2008 by The Hospital for Sick Children.
Recruitment status was Active, not recruiting

Study NCT00418847 Information provided by The Hospital for Sick Children

First Received on January 4, 2007. Last Updated on March 11, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Gangliosidoses GM2

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

miglustat

More general drug interventions related to this trial

Sponsors listed in this trial